Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ...

The science of PROTACs and MGDs. Traditional drug research has focused on creating inhibitors that occupy the active areas of ...

Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective ...

Within the next several years, using AI and cutting back on animal testing could reduce drug timelines and costs by at least ...

A new AI Drug Discovery tool called PDGrapher can predict more accurate drug combinations up to 25 times faster than previous ...

AI in drug discovery has carried promise and a nagging problem: models that predict without explaining. Vian Analytics steps ...

Enveda Biosciences has raised $300 million over the last year to make drugs to treat atopic dermatitis, asthma and more.

Discovering new medicines takes years and is marred by an astronomical failure rate. The Nobel Prize-winning head of Alphabet ...

Absci (ABSI) stock in focus as the company teams up with Oracle (ORCL) and AMD (AMD) to boost AI-powered drug discovery. Read ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Advanced Micro Devices (AMD) experienced a notable increase of 35% over the last quarter, amidst its key collaboration with ...

Using reprogrammed biocatalysts, researchers are pushing the boundaries of enzymatic synthesis with a method that opens the ...